Exactech (EXAC) Scheduled to Post Quarterly Earnings on Monday

Exactech (NASDAQ:EXAC) is set to announce its earnings results after the market closes on Monday, February 19th. Analysts expect the company to announce earnings of $0.38 per share for the quarter.

Shares of Exactech (NASDAQ EXAC) opened at $49.30 on Monday. The company has a current ratio of 4.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.06. Exactech has a 12-month low of $23.75 and a 12-month high of $50.95. The firm has a market cap of $708.25, a price-to-earnings ratio of 4,930.00, a P/E/G ratio of 3.64 and a beta of 0.90.

A number of analysts recently weighed in on EXAC shares. Robert W. Baird set a $34.00 price target on shares of Exactech and gave the stock a “buy” rating in a research report on Sunday, October 15th. Sidoti cut shares of Exactech from a “buy” rating to a “neutral” rating in a research report on Monday, October 23rd. Gabelli cut shares of Exactech from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. Zacks Investment Research cut shares of Exactech from a “hold” rating to a “sell” rating in a research report on Wednesday, October 25th. Finally, ValuEngine cut shares of Exactech from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Six research analysts have rated the stock with a hold rating, Exactech currently has an average rating of “Hold” and a consensus price target of $49.00.

COPYRIGHT VIOLATION WARNING: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/02/12/exactech-exac-scheduled-to-post-quarterly-earnings-on-monday.html.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Earnings History for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply